Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biophytis S.A. stock logo
BPTS
Biophytis
$13.37
$8.05
$168.80
$2.89M1.057,291 shs18,500 shs
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
$10.40
$10.39
$9.90
$11.00
$283.58MN/A167,770 shs23,136 shs
FWAA
Fifth Wall Acquisition Corp. I
$1.11
$12.40
$9.77
$12.92
$39.46MN/A368,485 shs758,860 shs
HCAQ
HealthCor Catalio Acquisition
$0.80
+10.3%
$8.72
$9.48
$11.00
$17.05MN/A114,974 shs408,654 shs
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
$1.81
-4.1%
$1.83
$0.95
$70.00
$5.74M0.79628,807 shs20,491 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biophytis S.A. stock logo
BPTS
Biophytis
0.00%0.00%0.00%0.00%0.00%
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
0.00%0.00%0.00%0.00%0.00%
FWAA
Fifth Wall Acquisition Corp. I
0.00%+19.30%+19.73%+3.74%-52.77%
HCAQ
HealthCor Catalio Acquisition
0.00%+7.87%-7.35%+15.81%-20.00%
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
0.00%+11.44%+13.39%+25.91%-87.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biophytis S.A. stock logo
BPTS
Biophytis
N/AN/AN/AN/AN/AN/AN/AN/A
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
N/AN/AN/AN/AN/AN/AN/AN/A
FWAA
Fifth Wall Acquisition Corp. I
N/AN/AN/AN/AN/AN/AN/AN/A
HCAQ
HealthCor Catalio Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biophytis S.A. stock logo
BPTS
Biophytis
0.00
N/AN/AN/A
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
0.00
N/AN/AN/A
FWAA
Fifth Wall Acquisition Corp. I
0.00
N/AN/AN/A
HCAQ
HealthCor Catalio Acquisition
0.00
N/AN/AN/A
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biophytis S.A. stock logo
BPTS
Biophytis
N/AN/AN/AN/A($17.29) per shareN/A
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
N/AN/A$1.94 per share5.36($1.68) per shareN/A
FWAA
Fifth Wall Acquisition Corp. I
N/AN/AN/AN/A$0.14 per shareN/A
HCAQ
HealthCor Catalio Acquisition
N/AN/AN/AN/AN/AN/A
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
$158.49K36.22N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biophytis S.A. stock logo
BPTS
Biophytis
-$18.43MN/A0.00N/AN/AN/AN/AN/AN/A
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
$24.09MN/A0.00N/AN/A-30.29%2.28%N/A
FWAA
Fifth Wall Acquisition Corp. I
N/AN/A0.00N/AN/AN/AN/AN/A
HCAQ
HealthCor Catalio Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
-$16.07MN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biophytis S.A. stock logo
BPTS
Biophytis
N/AN/AN/AN/AN/A
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
N/AN/AN/AN/AN/A
FWAA
Fifth Wall Acquisition Corp. I
N/AN/AN/AN/AN/A
HCAQ
HealthCor Catalio Acquisition
N/AN/AN/AN/AN/A
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biophytis S.A. stock logo
BPTS
Biophytis
N/A
0.72
0.72
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
N/A
0.07
0.07
FWAA
Fifth Wall Acquisition Corp. I
N/A
0.78
0.78
HCAQ
HealthCor Catalio Acquisition
N/A
0.48
0.48
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
N/A
2.64
2.63
CompanyEmployeesShares OutstandingFree FloatOptionable
Biophytis S.A. stock logo
BPTS
Biophytis
22351,000338,000Not Optionable
Churchill Capital Corp V stock logo
CCV
Churchill Capital Corp V
227.28 million21.82 millionNot Optionable
FWAA
Fifth Wall Acquisition Corp. I
235.55 millionN/ANot Optionable
HCAQ
HealthCor Catalio Acquisition
221.31 millionN/ANot Optionable
Meiwu Technology Company Limited stock logo
WNW
Meiwu Technology
503.17 millionN/ANot Optionable

Recent News About These Companies

Meiwu Falls on Shenzhen Hookup
Meiwu Technology Delays 20-F Filing
Meiwu Technology Company regains compliance with Nasdaq
Meiwu Technology Co Ltd trading halted, news pending
Meiwu Technology Company announces 1-for-20 reverse share split
Biophytis stock logo

Biophytis NASDAQ:BPTS

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

Churchill Capital Corp V stock logo

Churchill Capital Corp V NYSE:CCV

Churchill Capital Corp V does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as One Judith Acquisition Corp. Churchill Capital Corp V was incorporated in 2020 and is based in New York, New York.

Fifth Wall Acquisition Corp. I NASDAQ:FWAA

Fifth Wall Acquisition Corp. I focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in Los Angeles, California.

HealthCor Catalio Acquisition NASDAQ:HCAQ

HealthCor Catalio Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.

Meiwu Technology stock logo

Meiwu Technology NYSE:WNW

$1.81 -0.08 (-4.13%)
Closing price 03:59 PM Eastern
Extended Trading
$1.78 -0.04 (-2.04%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meiwu Technology Company Limited operates as an online and mobile commerce company in the People's Republic of China. It operates in three segments: Clean Food Platform, Restaurant, and others. The company offers green food, organic food, intangible cultural heritage food, agricultural products, and pollution-free products. It operates Clean Food Platform, an electronic online platform designs to provide primarily clean food to customers in China. The company also engages the provision of restaurant services; sells drinks, fruits, and frozen products; and wholesale of agricultural products, as well as provides short messages services and technical and consulting services. The company was formerly known as Wunong Net Technology Company Limited and changed its name to Meiwu Technology Company Limited in August 2021. Meiwu Technology Company Limited was founded in 2015 and is headquartered in Shenzhen, the People's Republic of China.